Assessment of immunogenicity and safety following primary and booster immunisation with a CRM197‐conjugated Haemophilus influenzae type b vaccine in healthy Chinese infants
1. Hebei Centre for Disease Control and Prevention, , Shijiazhuang, China;2. Centre for Disease Control and Prevention of Dingxing County, , Dingxing County, China;3. Novartis Vaccines and Diagnostics, , Beijing, China